Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

2.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation.

EClinicalMedicine·2026
Same author

CD59 drives diet-induced obesity and glucose intolerance, insulin resistance, and metabolic dysfunction-associated steatotic liver disease.

npj metabolic health and disease·2026
Same author

B cell Maturation Antigen Targeted Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus and Systemic Sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

RadD from <i>Fusobacterium nucleatum</i> engages NKp46 to promote antitumor cytotoxicity.

eLife·2026
Same author

Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy.

International journal of molecular sciences·2026
Same author

Impact of oral contrast use in CT imaging for acute appendicitis on time to surgery: a single-center before-after cohort study.

Annals of medicine and surgery (2012)·2026

Related Experiment Video

Updated: Dec 20, 2025

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.8K

Anti-RhD antibody therapy modulates human natural killer cell function.

Shlomo Elias1, Inbal Kol1, Shira Kahlon1

  • 1The Hebrew University Hadassah Medical School, Jerusalem, Israel.

Haematologica
|May 30, 2020
PubMed
Summary

Anti-RhD antibodies trigger natural killer (NK) cell degranulation by binding to CD16 receptors. This mechanism, dependent on antibody glycosylation, may reduce adaptive immunity activation, preventing RhD immunization.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.6K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.8K

Related Experiment Videos

Last Updated: Dec 20, 2025

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.8K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.6K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.8K

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Anti-RhD antibodies prevent RhD immunization, crucial for managing hemolytic disease of the fetus and newborn.
  • The precise mechanism of action for anti-RhD antibody prophylaxis remains largely unknown despite decades of clinical use.

Purpose of the Study:

  • To elucidate the mechanism by which anti-RhD antibodies exert their prophylactic effect.
  • To investigate the role of natural killer (NK) cells in the action of anti-RhD antibodies.

Main Methods:

  • Investigated NK cell degranulation upon exposure to anti-RhD antibodies in vitro.
  • Analyzed the binding of anti-RhD antibodies to the Fcγ receptor CD16 on NK cells.
  • Assessed the impact of anti-RhD antibody glycosylation on NK cell activation.
  • Studied NK cell degranulation in patients receiving prophylactic anti-RhD treatment.
  • Evaluated the effect of anti-RhD drug KamRho on dendritic cell killing.

Main Results:

  • Anti-RhD antibodies induce degranulation of human NK cells.
  • NK cell degranulation is mediated by the binding of the antibody's Fc segment to CD16, dependent on antibody glycosylation.
  • In vivo studies confirmed NK cell degranulation in patients treated with anti-RhD antibodies.
  • The anti-RhD drug KamRho was shown to enhance the killing of dendritic cells.

Conclusions:

  • Anti-RhD antibodies activate NK cells via CD16-Fc interaction, a process influenced by antibody glycosylation.
  • This NK cell activation and enhanced dendritic cell killing may contribute to reduced adaptive immune responses, explaining the prophylactic efficacy of anti-RhD therapy.